Rituximab for idiopathic membranous nephropathy: who can benefit?

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 4, 2006, Pages 738-748

  Ruggenenti, Piero ^a   Chiurchiu, Carlos ^a   Abbate, Mauro ^a   Perna, Annalisa ^a   Cravedi, Paolo ^a   Bontempelli, Mario ^a   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB;

ARTICLE; FEMALE; HUMAN; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PROSPECTIVE STUDY; PROTEINURIA; RETROSPECTIVE STUDY;

ANTIBODIES, MONOCLONAL; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 34548443784     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01080905     Document Type: Article

References (0)